Want to join the conversation?
Sidoti analyst John Franzeb asks what prevents $AZZ from looking at galvanizing acquisition opportunities in Europe. CEO Tom Ferguson said nothing prevents the company from doing it. He added that the acquisitions have to fit the company's profile, should add value and have to be big enough that it gives $AZZ some critical mass.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?